- Pfizer (New York, NY)
- …trial(s) in support of the development strategy for programs within the Late -Stage Oncology portfolio. **KEY RESPONSIBILITIES** + Clinical development expert for ... similar role in industry/CRO + Clinical Research experience in the phase 3/pivotal space in Oncology , ideally on the side of the sponsor and with a track record of… more
- AbbVie (Jersey City, NJ)
- …Tok (https://www.tiktok.com/@abbvie) . Job Description The Product Safety Team (PST) lead for late stage oncology products, under the direction of the Group Lead ... people's lives across several key therapeutic areas - immunology, oncology , neuroscience, and eye care - and products and...the development medical lead, setting the strategy for the oncology programs. PST lead will be responsible to one… more
- Pfizer (New York, NY)
- …+ Medical degree with 5+ years of industry experience + Clinical oncology experience (typically 4+ years) **Preferred Qualifications** Board certified/eligible in ... oncology or equivalent preferred Breast Oncology experience (2+ years) **Organizational Relationships** Reports to Global Development Lead and partners closely… more
- Merck (Rahway, NJ)
- …health. **Responsibilities:** This position supports statistical programming activities for late stage drug/vaccine clinical development projects. This may include ... leadership of one or more projects. Accountability predominantly includes the development and execution of statistical analysis and reporting deliverables (eg safety and efficacy analysis datasets, tables, listings, figures), the span of which range from… more
- Merck (Rahway, NJ)
- …position supports statistical programming activities for multiple and/or late stage drug/vaccine clinical development projects. Accountability predominantly includes ... Planning, Maintenance Strategy, Marketing, Microsoft Project, New Program Development, Oncology {+ 21 more} Current Employees apply HERE (https://wd5.myworkday.com/msd/d/task/1422$6687.htmld)… more
- Merck (Rahway, NJ)
- …imaging strategy for application of novel PET tracers in early clinical oncology trials, guiding projects from late -stage preclinical work through clinical ... Imaging Scientist to lead the transition of novel PET radiotracers from late preclinical development into first-in-human studies. This role will primarily focus on… more
- Sumitomo Pharma (New York, NY)
- …Europe (Sumitomo Pharma Switzerland GmbH) focused on addressing patient needs in oncology , urology, women's health, rare diseases, psychiatry & neurology, and cell & ... and Europe, and a diverse pipeline of early- to late -stage assets, we aim to accelerate discovery, research, and...Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene… more
- Regeneron Pharmaceuticals (Warren, NJ)
- …team and may contribute to candidate development projects through early and late phase development. The Director reports to the Senior Director Clinical Sciences ... design, and execute clinical research and development studies for early and late stage assets; able to conceive and communicate strategy proposals well-grounded in… more
- Bristol Myers Squibb (New Brunswick, NJ)
- …and post-marketing safety for the breadth of the BMS portfolio in oncology , hematology, cardiovascular disease, fibrosis, immunology and neurology. Located in any of ... + Act as a Nonclinical Safety representative on early- and late -stage project development teams. + Provides scientifically and strategically sound nonclinical… more
- Merck (Rahway, NJ)
- …Statistics and global PK/PD modeling and simulation stakeholders spanning both early and late in all our Company therapeutic areas except early oncology . The ... senior statistical programmer will gather and interpret user requirements for analysis and programming requests in close collaboration with stakeholders (statisticians/modelers) and clinical colleagues, retrieve the required data, transform the data into… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . TPA is rapidly expanding its operations across all functional areas. TPA's commitment ... to patients and their communities continues with a robust late -stage pipeline of investigational treatments for difficult-to-treat diseases and commercializing… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . TPA is rapidly expanding its operations across all functional areas. TPA's commitment ... to patients and their communities continues with a robust late -stage pipeline of investigational treatments for difficult-to-treat diseases and commercializing… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . TPA is rapidly expanding its operations across all functional areas. TPA's commitment ... to patients and their communities continues with a robust late -stage pipeline of investigational treatments for difficult-to-treat diseases and commercializing… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . TPA is rapidly expanding its operations across all functional areas. TPA's commitment ... to patients and their communities continues with a robust late -stage pipeline of investigational treatments for difficult-to-treat diseases and commercializing… more